OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<p>Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia</p>
Dimitri J. Maamari, Habib El‐Khoury, Omran Saifi, et al.
Pharmacogenomics and Personalized Medicine (2020) Vol. Volume 13, pp. 295-317
Open Access | Times Cited: 14
Dimitri J. Maamari, Habib El‐Khoury, Omran Saifi, et al.
Pharmacogenomics and Personalized Medicine (2020) Vol. Volume 13, pp. 295-317
Open Access | Times Cited: 14
Showing 14 citing articles:
Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
Patrycja Śliwa-Tytko, Agnieszka Kaczmarska, Monika Lejman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5515-5515
Open Access | Times Cited: 29
Patrycja Śliwa-Tytko, Agnieszka Kaczmarska, Monika Lejman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5515-5515
Open Access | Times Cited: 29
Prognostic impact of clinical and genetic factors on delayed elimination of methotrexate in children with acute lymphoblastic leukemia
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев, et al.
Pharmacokinetics and Pharmacodynamics (2025), Iss. 4, pp. 29-38
Open Access
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев, et al.
Pharmacokinetics and Pharmacodynamics (2025), Iss. 4, pp. 29-38
Open Access
Integrating pharmacogenomics in three Middle Eastern countries’ healthcare (Lebanon, Qatar, and Saudi Arabia): Current insights, challenges, and strategic directions
Saïd El Shamieh, Rida Saleem, Dalal Hammoudi Halat, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0319042-e0319042
Open Access
Saïd El Shamieh, Rida Saleem, Dalal Hammoudi Halat, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0319042-e0319042
Open Access
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia
Tales Henrique Andrade da Mota, Ricardo Camargo, Estefânia Rodrigues Biojone, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 691-691
Open Access | Times Cited: 7
Tales Henrique Andrade da Mota, Ricardo Camargo, Estefânia Rodrigues Biojone, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 691-691
Open Access | Times Cited: 7
Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia
Clara Vicente‐Garcés, Elena Esperanza‐Cebollada, Sara Montesdeoca, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
Clara Vicente‐Garcés, Elena Esperanza‐Cebollada, Sara Montesdeoca, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
Translating Precision Health for Pediatrics: A Scoping Review
Mathushan Subasri, Céline Cressman, Danielle Arje, et al.
Children (2023) Vol. 10, Iss. 5, pp. 897-897
Open Access | Times Cited: 3
Mathushan Subasri, Céline Cressman, Danielle Arje, et al.
Children (2023) Vol. 10, Iss. 5, pp. 897-897
Open Access | Times Cited: 3
Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
Gabriela Burgueño‐Rodríguez, Yessika Méndez, Natalia Olano, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Gabriela Burgueño‐Rodríguez, Yessika Méndez, Natalia Olano, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
A GRIN3A Polymorphism may be Associated with Glucocorticoid-Induced Symptomatic Osteonecrosis in Children with Acute Lymphoblastic Leukemia
Nathalie K. Zgheib, Habib El‐Khoury, Dimitri J. Maamari, et al.
Personalized Medicine (2021) Vol. 18, Iss. 5, pp. 431-439
Closed Access | Times Cited: 4
Nathalie K. Zgheib, Habib El‐Khoury, Dimitri J. Maamari, et al.
Personalized Medicine (2021) Vol. 18, Iss. 5, pp. 431-439
Closed Access | Times Cited: 4
Impact of the homozygous mutation in Nudix hydrolase 15 on myelosuppression with 6-mercaptopurine in a European girl with acute lymphoblastic leukemia: A case report
Laura Elena Pineda-Lancheros, María del Mar Sánchez-Suárez, Luciana María Marangoni-Iglecias, et al.
Ars Pharmaceutica (Internet) (2023) Vol. 64, Iss. 3, pp. 286-291
Open Access | Times Cited: 1
Laura Elena Pineda-Lancheros, María del Mar Sánchez-Suárez, Luciana María Marangoni-Iglecias, et al.
Ars Pharmaceutica (Internet) (2023) Vol. 64, Iss. 3, pp. 286-291
Open Access | Times Cited: 1
Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia
Deyanira Escalante-Bautista, Doris Cerecedo, Elva Jiménez‐Hernández, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
Deyanira Escalante-Bautista, Doris Cerecedo, Elva Jiménez‐Hernández, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
A review of pharmacogenetic aspects of methotrexate and 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia treatment
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев
Russian Journal of Pediatric Hematology and Oncology (2021) Vol. 8, Iss. 3, pp. 79-85
Open Access | Times Cited: 2
О. D. Gurieva, Marina I. Savelyevа, Т. Т. Валиев
Russian Journal of Pediatric Hematology and Oncology (2021) Vol. 8, Iss. 3, pp. 79-85
Open Access | Times Cited: 2
Novel Aspects of Leukemia Pharmacogenomics
Deyanira Escalante-Bautista, Rosas-Vargas Haydeé, Doris Cerecedo
Leukemia (2022), pp. 147-164
Open Access | Times Cited: 1
Deyanira Escalante-Bautista, Rosas-Vargas Haydeé, Doris Cerecedo
Leukemia (2022), pp. 147-164
Open Access | Times Cited: 1
Childhood Outcome Disparities in Cancer Care
Lorna Renner
Springer eBooks (2023), pp. 1-13
Closed Access
Lorna Renner
Springer eBooks (2023), pp. 1-13
Closed Access
Оценка токсичности терапии метотрексатом на основе фармакогенетического тестирования при остром лимфобластном лейкозе у детей
О. Д. Гурьева, М. И. Савельева, Т. Т. Валиев
Pharmacogenetics and Pharmacogenomics (2022), Iss. 2, pp. 6-7
Open Access
О. Д. Гурьева, М. И. Савельева, Т. Т. Валиев
Pharmacogenetics and Pharmacogenomics (2022), Iss. 2, pp. 6-7
Open Access
